Skip to main content
Search Query
Show Search
Home
Programs
Program Schedule
Propose A Program
Shows A-Z
Program Schedule
Propose A Program
Shows A-Z
News
Arts & Culture
Business
Community
Criminal Justice
Education
Environment
Government
Health
Housing
NPR (National) News
Arts & Culture
Business
Community
Criminal Justice
Education
Environment
Government
Health
Housing
NPR (National) News
Support Us
Donate Now
Donate a Vehicle
Our Underwriters
Studio Rental
Transfer Securities
Underwriting
Volunteer
Donate Now
Donate a Vehicle
Our Underwriters
Studio Rental
Transfer Securities
Underwriting
Volunteer
About Us
Contact Us
Staff
Governance
History
Jobs
Privacy Policy
Contact Us
Staff
Governance
History
Jobs
Privacy Policy
Coverage Map
Community Calendar
Podcasts
PSA Policy
© 2026
Menu
A Public Service of Santa Fe Community College
Show Search
Search Query
Play Live Radio
Next Up:
0:00
0:00
0:00
0:00
Available On Air Stations
On Air
Now Playing
KSFR
All Streams
Home
Programs
Program Schedule
Propose A Program
Shows A-Z
Program Schedule
Propose A Program
Shows A-Z
News
Arts & Culture
Business
Community
Criminal Justice
Education
Environment
Government
Health
Housing
NPR (National) News
Arts & Culture
Business
Community
Criminal Justice
Education
Environment
Government
Health
Housing
NPR (National) News
Support Us
Donate Now
Donate a Vehicle
Our Underwriters
Studio Rental
Transfer Securities
Underwriting
Volunteer
Donate Now
Donate a Vehicle
Our Underwriters
Studio Rental
Transfer Securities
Underwriting
Volunteer
About Us
Contact Us
Staff
Governance
History
Jobs
Privacy Policy
Contact Us
Staff
Governance
History
Jobs
Privacy Policy
Coverage Map
Community Calendar
Podcasts
PSA Policy
Support KSFR today!
Search results for
Sort By
Relevance
Newest (Publish Date)
Oldest (Publish Date)
Search
How monoclonal antibodies lost the fight with new COVID variants
The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.
Listen
•
3:32
Why remdesivir, a highly effective COVID treatment, is a last resort for providers
The antiviral infusion was just revived as an early treatment for COVID patients. But the drug is relatively expensive and hard to administer, relegating it to what some are calling "stopgap" status.
Listen
•
4:03
Once rare, lung transplants for COVID-19 patients are rising quickly
When it comes to receiving organ transplants, patients are not usually judged on prior behavior, but some doctors are questioning whether unvaccinated COVID patients should qualify for new lungs.
Listen
•
4:36
Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine
Though people who are vaccinated and boosted appear to be better protected against omicron, the highly contagious variant has still led to breakthrough cases and a surge in infections worldwide.
New VA study finds Paxlovid may cut the risk of long COVID
For those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.
Tonga's COVID outbreak is growing rapidly with omicron cases confirmed
Health Minister Saia Piukala told reporters that 31 more people had tested positive for the COVID-19, nearly doubling Tonga's active cases for the second day in a row, local media reported.
PHOTOS: Why South Africans Built An Illegal Settlement Called Covid
The pandemic pushed many South Africans out of work. Some grabbed land and put up shacks. There's a community called "Covid" — and even "Sanitizer." The Anti-Land Invasion Unit aims to tear them down.
What to do if you test positive for COVID at this point in the pandemic
The coronavirus keeps evolving and so does the guidance for addressing it. As cases tick up in some parts of the country, here is the latest advice on everything from testing to treatment.
Listen
•
3:36
The COVID public health emergency ends this week. Here's what's changing
Three years ago, the emergency declaration enabled certain tools for fighting the pandemic and protecting Americans. Now that it's expiring, here's what is changing — and what's not.
Confusion and falsehoods spread as China reverses its 'zero-COVID' policy
As China lifts its stringent zero-COVID policy, public health messaging has taken a U-turn. People are grappling with the whiplash, trying to find a way to protect themselves and loved ones.
Previous
50 of 747
Next